Fibrillogenesis and Cytotoxic Activity of the Amyloid-forming Apomyoglobin Mutant W7FW14F*
暂无分享,去创建一个
[1] S. Radford,et al. Hierarchical Assembly of β2-Microglobulin Amyloid In Vitro Revealed by Atomic Force Microscopy , 2003 .
[2] B. Shastry. Neurodegenerative disorders of protein aggregation , 2003, Neurochemistry International.
[3] K. L. Weiland,et al. Identification of a Mutant Amyloid Peptide That Predominantly Forms Neurotoxic Protofibrillar Aggregates* , 2003, Journal of Biological Chemistry.
[4] P. Lansbury,et al. Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease. , 2003, Biochemistry.
[5] Carl W. Cotman,et al. Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.
[6] G. Irace,et al. Hexafluoroisopropanol and acid destabilized forms of apomyoglobin exhibit structural differences. , 2003, Biochemistry.
[7] M. Papa,et al. Tryptophanyl Substitutions in Apomyoglobin Determine Protein Aggregation and Amyloid-like Fibril Formation at Physiological pH* , 2002, Journal of Biological Chemistry.
[8] D. Teplow,et al. Kinetic Studies of Amyloid β-Protein Fibril Assembly , 2002, The Journal of Biological Chemistry.
[9] T. Lachlan-Cope,et al. Climate change (Communication arising): Recent temperature trends in the Antarctic , 2002, Nature.
[10] Rustam Azimov,et al. The channel hypothesis of Alzheimer’s disease: current status , 2002, Peptides.
[11] V. Uversky,et al. Elucidation of the Molecular Mechanism during the Early Events in Immunoglobulin Light Chain Amyloid Fibrillation , 2002, The Journal of Biological Chemistry.
[12] J. Weissman,et al. Origins and kinetic consequences of diversity in Sup35 yeast prion fibers , 2002, Nature Structural Biology.
[13] W. K. Cullen,et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.
[14] C. Dobson,et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.
[15] A. Fersht,et al. Loss of a metal-binding site in gelsolin leads to familial amyloidosis–Finnish type , 2002, Nature Structural Biology.
[16] T. Pillot,et al. The nonfibrillar amyloid beta-peptide induces apoptotic neuronal cell death: involvement of its C-terminal fusogenic domain. , 2002, Journal of neurochemistry.
[17] C. Dobson,et al. A Partially Structured Species of β2-Microglobulin Is Significantly Populated under Physiological Conditions and Involved in Fibrillogenesis* , 2001, The Journal of Biological Chemistry.
[18] J. Kelly,et al. Furin initiates gelsolin familial amyloidosis in the Golgi through a defect in Ca2+ stabilization , 2001, The EMBO journal.
[19] C. Dobson,et al. Preparation and characterization of purified amyloid fibrils. , 2001, Journal of the American Chemical Society.
[20] S. Younkin,et al. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation , 2001, Nature Neuroscience.
[21] B. Caughey,et al. Reversibility of Scrapie-associated Prion Protein Aggregation* , 2001, The Journal of Biological Chemistry.
[22] C. Dobson,et al. Amyloid fibril formation by a helical cytochrome , 2001, FEBS letters.
[23] Christopher M. Dobson,et al. Amyloid fibrils from muscle myoglobin , 2001, Nature.
[24] S. Lindquist,et al. Bidirectional amyloid fiber growth for a yeast prion determinant , 2001, Current Biology.
[25] C. Dobson,et al. Formation of mixed fibrils demonstrates the generic nature and potential utility of amyloid nanostructures , 2000 .
[26] R. Casadio,et al. Predictions of protein segments with the same aminoacid sequence and different secondary structure: A benchmark for predictive methods , 2000, Proteins.
[27] R. Casadio,et al. The effect of tryptophanyl substitution on folding and structure of myoglobin. , 2000, European journal of biochemistry.
[28] Hai Lin,et al. Fresh and nonfibrillar amyloid β protein(1–40) induces rapid cellular degeneration in aged human fibroblasts: evidence for AβP‐channel‐mediated cellular toxicity , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] C M Dobson,et al. Chemical dissection and reassembly of amyloid fibrils formed by a peptide fragment of transthyretin. , 2000, Journal of molecular biology.
[30] P. Lansbury,et al. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[31] A. Monji,et al. Inhibition of Aβ fibril formation and Aβ-induced cytotoxicity by senile plaque-associated proteins , 2000, Neuroscience Letters.
[32] P. Fraser,et al. Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth. , 1999, European journal of biochemistry.
[33] Dominic M. Walsh,et al. Protofibrillar Intermediates of Amyloid β-Protein Induce Acute Electrophysiological Changes and Progressive Neurotoxicity in Cortical Neurons , 1999, The Journal of Neuroscience.
[34] C. Wurth,et al. The most pathogenic transthyretin variant, L55P, forms amyloid fibrils under acidic conditions and protofilaments under physiological conditions. , 1999, Biochemistry.
[35] D. Selkoe,et al. Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. , 1999, The Journal of biological chemistry.
[36] C. Dobson. Protein misfolding, evolution and disease. , 1999, Trends in biochemical sciences.
[37] C M Dobson,et al. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[38] K. Abe,et al. Amyloid β protein inhibits cellular MTT reduction not by suppression of mitochondrial succinate dehydrogenase but by acceleration of MTT formazan exocytosis in cultured rat cortical astrocytes , 1998, Neuroscience Research.
[39] E. Bismuto,et al. Apomyoglobin folding intermediates characterized by the hydrophobic fluorescent probe 8-anilino-1-naphthalene sulfonate. , 1998, Biochimica et biophysica acta.
[40] T. Morgan,et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[41] I D Campbell,et al. Amyloid fibril formation by an SH3 domain. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[42] C. Blake,et al. From the globular to the fibrous state: protein structure and structural conversion in amyloid formation , 1998, Quarterly Reviews of Biophysics.
[43] A. Fink. Protein aggregation: folding aggregates, inclusion bodies and amyloid. , 1998, Folding & design.
[44] P E Wright,et al. Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[45] D. Schubert,et al. Cytotoxic Amyloid Peptides Inhibit Cellular 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐Diphenyltetrazolium Bromide (MTT) Reduction by Enhancing MTT Formazan Exocytosis , 1997, Journal of neurochemistry.
[46] P. Lansbury,et al. Scrapie infectivity correlates with converting activity, protease resistance, and aggregation of scrapie-associated prion protein in guanidine denaturation studies , 1997, Journal of virology.
[47] Christopher M. Dobson,et al. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis , 1997, Nature.
[48] J. Kelly,et al. Alternative conformations of amyloidogenic proteins govern their behavior. , 1996, Current opinion in structural biology.
[49] E. Gratton,et al. Pressure-induced perturbation of apomyoglobin structure: fluorescence studies on native and acidic compact forms. , 1996, Biochemistry.
[50] M. Shearman,et al. The Intracellular Component of Cellular 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐Diphenyltetrazolium Bromide (MTT) Reduction Is Specifically Inhibited by β‐Amyloid Peptides , 1995 .
[51] M. Kataoka,et al. Structural characterization of the molten globule and native states of apomyoglobin by solution X-ray scattering. , 1995, Journal of molecular biology.
[52] R. Wetzel,et al. Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.
[53] P. Roller,et al. Scrapie amyloid (prion) protein has the conformational characteristics of an aggregated molten globule folding intermediate. , 1994, Biochemistry.
[54] L. Iversen,et al. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[55] E. Bismuto,et al. Solvent and thermal denaturation of the acidic compact state of apomyoglobin , 1994, FEBS letters.
[56] P E Wright,et al. Formation of a molten globule intermediate early in the kinetic folding pathway of apomyoglobin. , 1993, Science.
[57] H. Levine,et al. Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution , 1993, Protein science : a publication of the Protein Society.
[58] E. Bismuto,et al. Salt-induced refolding of myoglobin at acidic pH: molecular properties of a partly folded intermediate. , 1992, Archives of biochemistry and biophysics.
[59] K. Higuchi,et al. Kinetic analysis of amyloid fibril polymerization in vitro. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[60] P E Wright,et al. Structural characterization of a partly folded apomyoglobin intermediate. , 1990, Science.
[61] M. Hansen,et al. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. , 1989, Journal of immunological methods.
[62] M. Hosokawa,et al. Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. , 1989, Analytical biochemistry.
[63] D. Eisenberg,et al. Analysis of membrane and surface protein sequences with the hydrophobic moment plot. , 1984, Journal of molecular biology.
[64] H. Edelhoch,et al. Spectroscopic determination of tryptophan and tyrosine in proteins. , 1967, Biochemistry.
[65] L. Stryer,et al. The interaction of a naphthalene dye with apomyoglobin and apohemoglobin. A fluorescent probe of non-polar binding sites. , 1965, Journal of molecular biology.
[66] Y. Liu,et al. Amyloid beta peptide alters intracellular vesicle trafficking and cholesterol homeostasis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[67] Satoru Suzuki,et al. Establishment of a kinetic model of dialysis-related amyloid fibril extension in vitro , 1997 .
[68] A. Fink,et al. Acid-induced folding of proteins. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[69] J T Yang,et al. Calculation of protein conformation from circular dichroism. , 1986, Methods in enzymology.
[70] F. Teale,et al. Cleavage of the haem-protein link by acid methylethylketone. , 1959, Biochimica et biophysica acta.